PRO140 (leronlimab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRO140 (leronlimab), covering 2025-10-30 to 2025-10-30. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study [Phase 2, Phase 3]